Leonteq Securities’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32K Sell
384
-603
-61% -$49.6K ﹤0.01% 855
2026
Q2
$65.6K Buy
987
+977
+9,770% +$82.7K ﹤0.01% 758
2026
Q1
$994 Sell
10
-188
-95% -$24.5K ﹤0.01% 1194
2025
Q4
$24.1K Sell
198
-579
-75% -$72.7K ﹤0.01% 1058
2025
Q3
$87.2K Buy
777
+719
+1,240% +$84.2K ﹤0.01% 780
2025
Q2
$7.77K Sell
58
-3,086
-98% -$339K ﹤0.01% 1094
2025
Q1
$211K Buy
3,144
+1,185
+60% +$81.5K 0.01% 535
2024
Q4
$122K Buy
1,959
+1,586
+425% +$148K 0.01% 644
2024
Q3
$58.6K Buy
373
+320
+604% +$49.3K ﹤0.01% 721
2024
Q2
$7.98K Sell
53
-1,065
-95% -$128K ﹤0.01% 1004
2024
Q1
$82.7K Buy
1,118
+688
+160% +$56.7K 0.01% 671
2023
Q4
$33.9K Buy
+430
New +$25.9K ﹤0.01% 852
2023
Q2
– Sell
-1,229
Closed -$93.1K – 1313
2023
Q1
$93.1K Hold
1,229
– – ﹤0.01% 657
2022
Q4
$75.9K Buy
+1,229
New +$65.3K ﹤0.01% 730

Other funds holding TMDX

Leonteq Securities's TMDX Position: Q3 2026 in Review

Leonteq Securities reduced its Transmedics (TMDX) stake by 61% in Q3 2026, selling an estimated $49.6K and leaving 384 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

Leonteq Securities first reported a position in TMDX in Q4 2022 and has held it in 14 quarters since. The position peaked at $211K in Q1 2025. 306 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Leonteq Securities held 384 shares of Transmedics worth $32K as of Q3 2026.
  • Leonteq Securities sold 603 Transmedics shares in Q3 2026, an estimated $49.6K.
  • Transmedics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #855 holding.
  • Leonteq Securities first reported a position in Transmedics in Q4 2022 and has held it in 14 quarters since.
  • Leonteq Securities's Transmedics position peaked at $211K in Q1 2025.
  • 306 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.